nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia
|
Boccardi, Marina |
|
2018 |
45 |
9 |
p. 1470-1486 |
artikel |
2 |
Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders
|
Nobili, Flavio |
|
2018 |
45 |
9 |
p. 1557-1566 |
artikel |
3 |
Brain FDG-PET: clinical use in dementing neurodegenerative conditions
|
Nobili, Flavio |
|
2018 |
45 |
9 |
p. 1467-1469 |
artikel |
4 |
Clinical utility of FDG-PET for the clinical diagnosis in MCI
|
Arbizu, Javier |
|
2018 |
45 |
9 |
p. 1497-1508 |
artikel |
5 |
Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia
|
Nestor, Peter J. |
|
2018 |
45 |
9 |
p. 1509-1525 |
artikel |
6 |
Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington’s disease
|
Agosta, Federica |
|
2018 |
45 |
9 |
p. 1546-1556 |
artikel |
7 |
Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia
|
Walker, Zuzana |
|
2018 |
45 |
9 |
p. 1534-1545 |
artikel |
8 |
Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia
|
Bouwman, Femke |
|
2018 |
45 |
9 |
p. 1526-1533 |
artikel |
9 |
Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer’s disease
|
Drzezga, Alexander |
|
2018 |
45 |
9 |
p. 1487-1496 |
artikel |
10 |
Dual tracer tau PET imaging reveals different molecular targets for 11C-THK5351 and 11C-PBB3 in the Alzheimer brain
|
Chiotis, Konstantinos |
|
2018 |
45 |
9 |
p. 1605-1617 |
artikel |
11 |
18F-FDG PET and high-resolution MRI co-registration for pre-surgical evaluation of patients with conventional MRI-negative refractory extra-temporal lobe epilepsy
|
Ding, Yao |
|
2018 |
45 |
9 |
p. 1567-1572 |
artikel |
12 |
Integrated analysis of dynamic FET PET/CT parameters, histology, and methylation profiling of 44 gliomas
|
Röhrich, Manuel |
|
2018 |
45 |
9 |
p. 1573-1584 |
artikel |
13 |
Noradrenaline transporter availability on [11C]MRB PET predicts weight loss success in highly obese adults
|
Vettermann, Franziska J. |
|
2018 |
45 |
9 |
p. 1618-1625 |
artikel |
14 |
Prolonged survival in secondary glioblastoma following local injection of targeted alpha therapy with 213Bi-substance P analogue
|
Krolicki, Leszek |
|
2018 |
45 |
9 |
p. 1636-1644 |
artikel |
15 |
Quantitative evaluation of tau PET tracers 18F-THK5351 and 18F-AV-1451 in Alzheimer’s disease with standardized uptake value peak-alignment (SUVP) normalization
|
Chen, Jingyun |
|
2018 |
45 |
9 |
p. 1596-1604 |
artikel |
16 |
The role of 18F-FP-CIT PET in differentiation of progressive supranuclear palsy and frontotemporal dementia in the early stage
|
Yoo, Han Soo |
|
2018 |
45 |
9 |
p. 1585-1595 |
artikel |
17 |
Use of FET PET in glioblastoma patients undergoing neurooncological treatment including tumour-treating fields: initial experience
|
Ceccon, Garry |
|
2018 |
45 |
9 |
p. 1626-1635 |
artikel |